COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- The Inhibitory Effect of Selenium Supplementation on Tumor Progression in a DMBA-Induced Breast Cancer Model in Wistar Rats
- Rapid survey on lifestyle changes and body weight gain among Algerians during COVID-19 lockdown
- Effects of the Withania somnifera supplementation on sports performance: a systematic review and meta-analysis
- Differences in dietary intake between Turkish vegans and omnivores: a cross-sectional study
- Nutritional status and nutrient adequacy of food consumed by non-academic staff in a Nigerian university
- Effects of fermentation period and soybean flour supplementation on the glycemic indices and starch digestibility of biofortified provitamin A cassava meal
- Association between 24-hour urinary sodium and iodine in a Beninese population
- Effect of acute supplementation of hibiscus-ginger drink on university athletes’ aerobic power and blood lactate
- Nutritional and Bioactive Profile of Gitumon: An Indonesian Traditional Herbal Beverage
- Sports supplements: use, knowledge, and risks for Algerian athletes
You may also start an advanced similarity search for this article.

NAJFNR is licensed under